PROGNOSIS OF HEART FAILURE FOLLOWING CARDIOTOXIC BREAST CANCER CHEMOTHERAPY: A RETROSPECTIVE MATCHED COHORT STUDY

2020 
Cardiotoxic chemotherapy for early-stage breast cancer (EBC) increases the risk of heart failure (HF) but there are limited data on its prognosis relative to HF from other etiologies. Using administrative databases, we conducted a retrospective population-based matched cohort study of women newly
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []